You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Novel Fractionation and Concentration System for Preparation Improved Biological Detection
SBC: INNOVAPREP LLC Topic: HSB0111002Detection of bioaerosols is a cornerstone in the protection of our nation from bioterrorist events. Rapid bioaerosol detection systems have advanced dramatically in recent years, but the lack of integratable automated sample preparation for these systems remains a major deficiency. Three significant issues associated with current sample preparation components in these systems are (a) a lack of an ...
SBIR Phase I 2011 Department of Homeland Security -
SBIR Phase I: Advanced Portable Power Generators
SBC: QM Power, Inc. Topic: ICThis Small Business Innovation Research (SBIR) Phase I project evaluates a completely new low cost/high efficiency generator system called Q-Gen? Portable for use in portable recharging devices. The Q-Gen? Portable will recharge handheld electronic devices (laptops, cell phones etc) without requiring the grid or a fuel source. In addition, an initial analysis suggests that utilizing QM Power actua ...
SBIR Phase I 2011 National Science Foundation -
SBIR Phase II: Inhibition-Resistant DNA Polymerases and Other Improvements for Detection of Food-borne Pathogens.
SBC: DNA POLYMERASE TECHNOLOGY, INC. Topic: PhaseIIThis Small Business Innovation Research (SBIR) Phase II project proposes the development of novel enzymes (DNA polymerases) and other improvements for rapid detection of food-borne pathogens by DNA detection and amplification (PCR). PCR is a very fast and accurate method of pathogen detection, typically giving results in about a day, instead of several days required to grow and identify pathogens ...
SBIR Phase II 2011 National Science Foundation -
Multi-day Pain Management Therapy with Novel Injectable Formulation
SBC: ORBIS BIOSCIENCES, INC. Topic: NIDADESCRIPTION (provided by applicant): Our long term goal is to widespread the use of PPF technology for promoting effective production of drug-encapsulating microparticles with uniform size and physical characteristics that can be leveraged to release a specific drug at controlled rates over multi-day periods in vivo after a single administration. For this proposal, we are specifically targeting a ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Anti-CD47 mAb Therapy to Improve Kidney Transplantation
SBC: VASCULOX, INC. Topic: NIDDKDESCRIPTION (provided by applicant): Organ transplantation is one of the great success stories of modern medicine. However, the supply of suitable organs lags far behind the need and many patients die while waitlisted for organs. While there have been manyrecent strides in organ procurement, preservation and follow-up immune suppression, prevention of ischemia-reperfusion injury (IRI) remains prob ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Nanocomposite Imaging System for the Eye
SBC: KYPHA INC. Topic: NEIDESCRIPTION (provided by applicant): The purpose of this SBIR project is to develop a new dual-modality inflammation imaging technology to early detect Uveitis, an ocular inflammation-related disorder. This technology, based on nanocomposites (NCs) that function as dual-modality fluorescent and acoustic contrast agents for optical and ultrasound imaging techniques, will allow both quantitative ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Controlled Release of Topical Nitric Oxide for Treating Cutaneous Injuries
SBC: SARMONT, LLC Topic: NIGMSDESCRIPTION (provided by applicant): Nitric oxide (NO) has been shown to have powerful, broad-spectrum antimicrobial activity as well as benefits in wound healing when properly administered [1-3]. The combination of these two attributes makes development of a non-systemic NO delivery approach valuable for hospital and outpatient applications to prevent infection and accelerate wound healing. Such ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Enhanced system for atrial defibrillation
SBC: CARDIALEN, INC. Topic: NHLBIDESCRIPTION (provided by applicant): Atrial fibrillation (AF) is the most prevalent clinical arrhythmia in clinical practice and a major contributor to morbidity and mortality. A recent study estimated that the number of Americans afflicted by AF will increase from the current range of 2.2 to 5.6 million to more than 12 million by 2050. This increase will be driven significantly by demographics, s ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Development of a prototype system for assaying exocytosis from individual cells
SBC: EXOCYTRONICS, LLC Topic: NIMHDESCRIPTION (provided by applicant): Cells secrete hormones and neurotransmitter via exocytosis. Understanding how exocytosis is regulated and how pharmaceuticals and toxins inhibit exocytosis is of broad medical significance. The overall goal of this SBIRproject is to use microfabrication technology to develop a robust and easy-to-use prototype device that can assay release of transmitter from in ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Improved long-term biocompatibility of coronary stents by plasma coating process
SBC: NANOVA INC. Topic: NHLBIDESCRIPTION (provided by applicant): Improved long-term biocompatibility of coronary stents by plasma coating process Abstract Drug-eluting stents (DES) have been widely used to treat patients of cardiac disease due to their better ability to control restenosis than bare metal stents (BMS). However, a serious adverse outcome of late stent thrombosis in patients treated with DES has been reported, ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health